Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Subarachnoid hemorrhage

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44335   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    55 result(s) found for: Subarachnoid hemorrhage. Displaying page 1 of 3.
    1  2  3  Next»
    EudraCT Number: 2011-002798-50 Sponsor Protocol Number: prostacyclin Start Date*: 2011-09-27
    Sponsor Name:Rune Rasmussen
    Full Title: Effect of prostacyclin infusion on cerebral vessels and metabolism in patients with subarachnoid haemorrhage
    Medical condition: Vasospasm following subarachnoid hemorrhage
    Disease: Version SOC Term Classification Code Term Level
    14.0 10029205 - Nervous system disorders 10042320 Subarachnoid hemorrhage LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-000429-10 Sponsor Protocol Number: 17-030 Start Date*: 2017-10-24
    Sponsor Name:CHU CAEN
    Full Title: FIVHeMA: Intraventricular fibrinolysis versus external ventricular drainage alone in aneurysmal subarachnoid hemorrhage: a randomized controlled trial.
    Medical condition: Patients > 18 years, with aneurysmal SAH complicated by hydrocephalus, requiring insertion of external ventricular drainage
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000013702 10042320 Subarachnoid hemorrhage LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed) NO (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-008215-25 Sponsor Protocol Number: H-A-2008-109 Start Date*: 2009-05-05
    Sponsor Name:Walter Fischer
    Full Title: Behandling ved intraventrikulær blødning: Et pilotstudie af virkningen med tidlig intraventrikulær actilysebehandling.
    Medical condition: 1. Subarachnoidal blødning (SAH) med intraventrikulær blødning(IVH) 2. Spontan intraventrikulær blødning (IVH) uden påvist blodkarmisdannelse (AVM) 3. Randomiserede kontroller med SAH og IVH 4. ...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10019587 Hemorrhage subarachnoid LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2009-015784-13 Sponsor Protocol Number: 190476 Start Date*: 2011-02-18
    Sponsor Name:Teemu Luostarinen
    Full Title: Mannitolin ja hypertonisen keittosuolan vaikutus hemodynamiikkaan, happoemästasapainoon ja veren hyytymi-seen tavoiteohjatun nestehoidon aikana subaraknoidaalivuotopotilailla.
    Medical condition: Tutkittavilla henkilöillä on leikkausta vaativa aneurysmaattinen subaraknoidaalivuoto.
    Disease: Version SOC Term Classification Code Term Level
    12.1 10042316 Subarachnoid haemorrhage LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2019-000959-14 Sponsor Protocol Number: 29BRC18.0262 Start Date*: 2021-03-16
    Sponsor Name:CHRU de Brest
    Full Title: The NIPA study: A randomized double-blind control clinical trial Naloxegol administration to prevent opioids induced gastrointestinal motility disturbance in brain Injured PAtients.
    Medical condition: Prevent opioids induced gastrointestinal motility disturbance in brain Injured Patients.
    Disease: Version SOC Term Classification Code Term Level
    20.1 10017947 - Gastrointestinal disorders 10061173 Gastrointestinal motility disorder PT
    21.1 10029205 - Nervous system disorders 10042316 Subarachnoid haemorrhage PT
    20.0 100000004863 10078809 Skull trauma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2020-002433-15 Sponsor Protocol Number: RS200511 Start Date*: 2021-02-15
    Sponsor Name:Region Skåne
    Full Title: Positron emission tomography (PET) of patients with brain injury and athletes with concussion symptoms - Descriptive study of the tau tracer 18F-RO6958948
    Medical condition: Traumatic brain injury (TBI), cerebral haemorrhage (ICH), subarachnoid haemorrhage (SAH) and cerebral commotio.
    Disease: Version SOC Term Classification Code Term Level
    21.1 10022117 - Injury, poisoning and procedural complications 10070976 Craniocerebral injury PT
    20.1 100000004852 10042320 Subarachnoid hemorrhage LLT
    20.1 10022117 - Injury, poisoning and procedural complications 10060690 Traumatic brain injury LLT
    21.1 100000004852 10022754 Intracerebral hemorrhage LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2020-005731-67 Sponsor Protocol Number: NLxxxxxxxxxx Start Date*: 2021-07-02
    Sponsor Name:Haaglanden Medisch Centrum
    Full Title: Complement Inhibition: Attacking the Overshooting Inflammation @fter Subarachnoid Hemorrhage - A phase II trial on the safety and efficacy of C1 esterase inhibitor for the acute management of subar...
    Medical condition: Subarachnoid hemorrhage
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004852 10042320 Subarachnoid hemorrhage LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2015-005033-53 Sponsor Protocol Number: EG-01-1962-03 Start Date*: 2017-02-01
    Sponsor Name:Edge Therapeutics, Inc
    Full Title: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarac...
    Medical condition: Aneurysmal subarachnoid hemorrhage (aSAH)
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004863 10072200 Asymptomatic subarachnoid hemorrhage LLT
    20.1 100000004863 10042320 Subarachnoid hemorrhage LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) CZ (Completed) FI (Prematurely Ended) DK (Prematurely Ended) AT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2008-006785-29 Sponsor Protocol Number: AC-054-302 Start Date*: 2009-09-15
    Sponsor Name:Actelion Pharmaceuticals Ltd.
    Full Title: A prospective, multi-center, double-blind, randomized, placebo-controlled, parallel-group study to assess the efficacy and safety of clazosentan in reducing vasospasm-related morbidity and all-caus...
    Medical condition: Indication: Subarachnoid aneurysmal hemorrhage
    Disease: Version SOC Term Classification Code Term Level
    11 10042316 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Prematurely Ended) DK (Prematurely Ended) FI (Prematurely Ended) AT (Prematurely Ended) BE (Completed) CZ (Completed) FR (Completed) DE (Completed) SI (Prematurely Ended) ES (Prematurely Ended) HU (Prematurely Ended) IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2017-000868-15 Sponsor Protocol Number: P001151 Start Date*: 2019-01-15
    Sponsor Name:Medical Center -University of Freiburg
    Full Title: Stereotactic Cisternal Lavage in Patients with Aneurysmal Subarachnoid Hemorrhage with Urokinase and Nimodipine for the Prevention of Secondary Brain Injury. A Randomized Controlled Trial.
    Medical condition: Aneurysmal Subarachnoid Hemorrhage (aSAH)
    Disease: Version SOC Term Classification Code Term Level
    20.1 10029205 - Nervous system disorders 10042320 Subarachnoid hemorrhage LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2021-000586-33 Sponsor Protocol Number: 19-PP-15 Start Date*: 2021-07-21
    Sponsor Name:CHU de Nice
    Full Title: Effect of molar sodium lactate infusion on cerebral hemodynamic in patients with severe subarachnoid hemorrhage: a multicenter double-blind randomized controlled study
    Medical condition: Subarachnoid hemorrhage caused by rupture of cerebral aneurysm
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004852 10042320 Subarachnoid hemorrhage LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2021-000732-54 Sponsor Protocol Number: NCH-201803 Start Date*: 2021-10-11
    Sponsor Name:Rheinische Friedrich-Wilhelms-Universität Bonn
    Full Title: FINISHER - Fight Inflammation to Improve outcome after aneurysmal Subarachnoid Hemorrhage
    Medical condition: aneurysmal subarachnoid hemorrhage
    Disease: Version SOC Term Classification Code Term Level
    21.1 10029205 - Nervous system disorders 10042316 Subarachnoid haemorrhage PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2014-003284-38 Sponsor Protocol Number: EVG001SAH Start Date*: 2016-02-15
    Sponsor Name:Evgen Pharma plc
    Full Title: SFX-01 AFTER SUBARACHNOID HAEMORRHAGE
    Medical condition: Subarachnoid Haemorrhage
    Disease: Version SOC Term Classification Code Term Level
    20.1 10022117 - Injury, poisoning and procedural complications 10042316 Subarachnoid haemorrhage PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2017-004307-51 Sponsor Protocol Number: NL63723.041.17 Start Date*: 2018-06-13
    Sponsor Name:University Medical Center Utrecht
    Full Title: Complement C5 Antibodies for decreasing brain injury after aneurysmal Subarachnoid Hemorrhage: safety and proof-of-concept.
    Medical condition: Aneurysmal subarachnoid hemorrhage
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004852 10042320 Subarachnoid hemorrhage LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-002337-36 Sponsor Protocol Number: 2007neuro07/R013630/S1 Start Date*: 2008-06-06
    Sponsor Name:Salford Royal NHS Foundation Trust
    Full Title: An open-labelled study of the cerebrospinal fluid pharmacokinetics of intravenous Kineret® in patients with subarachnoid haemorrhage
    Medical condition: This is a pharmacokinetic study in patients who have had a Subarachnoid Haemorrhage and who have had an external ventricular drain inserted for clinical management reasons, must usually for the tre...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10042316 Subarachnoid haemorrhage LLT
    9.1 10052947 Ventricular drainage LLT
    9.1 10020508 Hydrocephalus LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-005836-98 Sponsor Protocol Number: 2008neuro25 Start Date*: 2009-02-11
    Sponsor Name:Salford Royal Foundation Trust
    Full Title: The effect of Kineret® on brain biomarkers in patients with subarachnoid haemorrhage
    Medical condition: Subarachnoid Haemorrhage
    Disease: Version SOC Term Classification Code Term Level
    9.1 10042316 Subarachnoid haemorrhage LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2011-001855-35 Sponsor Protocol Number: Start Date*: 2011-08-09
    Sponsor Name:Salford Royal NHS Foundation Trust
    Full Title: Does subcutaneous interleukin-1 receptor antagonist reduce inflammation following subarachnoid haemorrhage?
    Medical condition: Subarachnoid haemorrhage
    Disease: Version SOC Term Classification Code Term Level
    14.0 10029205 - Nervous system disorders 10042316 Subarachnoid haemorrhage PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2018-000241-39 Sponsor Protocol Number: ID-054-304 Start Date*: 2018-08-27
    Sponsor Name:Idorsia Pharmaceuticals Ltd
    Full Title: A prospective, multi-center, double-blind, randomized, placebo-controlled, parallel-group, Phase 3 study to assess the efficacy and safety of clazosentan in preventing clinical deterioration due to...
    Medical condition: Aneurysmal Subarachnoid Hemorrhage
    Disease: Version SOC Term Classification Code Term Level
    21.1 10029205 - Nervous system disorders 10039330 Ruptured cerebral aneurysm PT
    21.1 10029205 - Nervous system disorders 10042316 Subarachnoid haemorrhage PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed) DE (Completed) SE (Completed) FR (Completed) CZ (Completed) BE (Completed) DK (Completed) HU (Completed) AT (Completed) PL (Completed) ES (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2013-000954-23 Sponsor Protocol Number: EG-01-1962-02 Start Date*: 2015-02-13
    Sponsor Name:Edge Therapeutics, Inc.
    Full Title: PHASE 1/2a MULTICENTER, CONTROLLED, RANDOMIZED, OPEN LABEL, DOSE ESCALATION, SAFETY, TOLERABILITY, AND PHARMACOKINETIC STUDY COMPARING EG-1962 AND NIMODIPINE IN PATIENTS WITH ANEURYSMAL SUBARACHNOI...
    Medical condition: Aneurysmal subarachnoid hemorrhage
    Disease: Version SOC Term Classification Code Term Level
    17.1 100000004852 10042320 Subarachnoid hemorrhage LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed) FI (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2008-001909-41 Sponsor Protocol Number: 5070197 Start Date*: 2008-04-11
    Sponsor Name:Stepani Bendel
    Full Title: Hydrokortisonihoito elinluovutuspotilailla (HYDRO)
    Medical condition: Tutkittavilla on vakava aivovamma ja/tai lukinkalvonalainen verenvuoto, eikä heitä voida parantaa sairaudestaan. Heitä hoidetaan teho-osastolla mahdollisina elintenluovutuspotilaina.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10019587 Hemorrhage subarachnoid LLT
    9.1 10049054 Brain death LLT
    9.1 10052346 Brain contusion LLT
    9.1 10006117 Brain damage (traumatic) LLT
    Population Age: Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat May 10 07:28:33 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA